BOSTON SCIENTIFIC LAUNCHES WAVEWRITER ALPHA™ SPINAL CORD STIMULATOR SYSTEMS IN EUROPE-
SCS portfolio features full-body MRI conditional devices that combine therapy optionsfor personalized pain relief
Sept 30, 2020
Boston Scientific (NYSE: BSX) today announced the European launch of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) Systems. The portfolio, consisting of four MRI conditionali, Bluetooth-enabled implantable pulse generators (IPGs), offers expanded personalization based on patient needs, including rechargeable and non-rechargeable options, and access to waveforms that can cover multiple areas of pain…
Boston Scientific Launches Spectra WaveWriter™ Spinal Cord Stimulator System in Europe - Jan 31, 2019
Boston today announced the launch of the Spectra WaveWriter™ Spinal Cord Stimulator (SCS) System in Europe. The Spectra WaveWriter SCS System is the first and only system for the treatment of chronic pain to...
Boston Scientific Announces Positive Results from WHISPER Spinal Cord Stimulation Study - Jan 12, 2018
Boston announced today positive results from the WHISPER randomized controlled trial (RCT).
The data, presented at the 2018 Annual Meeting of the North American Neuromodulation Society in Las Vegas, demonstrated that patients who are given the choice to...
LUMINA Data Demonstrate 70 Percent Greater Low Back Pain Relief with Boston Scientific Precision Spectra™ Spinal Cord Stimulator System - Dec 11, 2015
Final results evaluating the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System demonstrate that the device provides more than 70 percent greater low back pain...
Boston Scientific launches the Precision NOVI™ Spinal Cord Stimulator System in Europe - Jun 04, 2015
Boston Scientific announces the European launch of the Precision Novi™ Spinal Cord Stimulator (SCS) System at the International Neuromodulation Society in Montreal, Canada.
Boston Scientific and Pain Alliance Europe now partner against chronic pain - Jan 21, 2015
Pain Alliance Europe (PAE) and Boston Scientific will start as of today a meaningful cooperation which will help both entities advance their mission.